-
Je něco špatně v tomto záznamu ?
Review about Structure and Evaluation of Reactivators of Acetylcholinesterase Inhibited with Neurotoxic Organophosphorus Compounds
JD. Figueroa-Villar, EC. Petronilho, K. Kuca, TCC. Franca
Jazyk angličtina Země Spojené arabské emiráty
Typ dokumentu časopisecké články, přehledy
- MeSH
- acetylcholinesterasa * MeSH
- cholinesterasové inhibitory toxicita MeSH
- lidé MeSH
- organofosforové sloučeniny toxicita MeSH
- oximy farmakologie MeSH
- počítačová simulace MeSH
- reaktivátory cholinesterasy * farmakologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
BACKGROUND: Neurotoxic chemical warfare agents can be classified as some of the most dangerous chemicals for humanity. The most effective of those agents are the Organophosphates (OPs) capable of restricting the enzyme Acetylcholinesterase (AChE), which in turn, controls the nerve impulse transmission. When AChE is inhibited by OPs, its reactivation can be usually performed through cationic oximes. However, until today, it has not been developed one universal defense agent, with complete effective reactivation activity for AChE inhibited by any of the many types of existing neurotoxic OPs. For this reason, before treating people intoxicated by an OP, it is necessary to determine the neurotoxic compound that was used for contamination, in order to select the most effective oxime. Unfortunately, this task usually requires a relatively long time, raising the possibility of death. Cationic oximes also display a limited capacity of permeating the Blood-Brain Barrier (BBB). This fact compromises their capacity to reactivating AChE inside the nervous system. METHODS: We performed a comprehensive search on the data about OPs available on the scientific literature today in order to cover all the main drawbacks still faced in the research for the development of effective antidotes against those compounds. RESULTS: Therefore, this review about neurotoxic OPs and the reactivation of AChE, provides insights for the new agents' development. The most expected defense agent is a molecule without toxicity and effective to reactivate AChE inhibited by all neurotoxic OPs. CONCLUSION: To develop these new agents, the application of diverse scientific areas of research, especially theoretical procedures as computational science (computer simulation, docking and dynamics), organic synthesis, spectroscopic methodologies, biology, biochemical and biophysical information, medicinal chemistry, pharmacology and toxicology, is necessary.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019508
- 003
- CZ-PrNML
- 005
- 20210830101105.0
- 007
- ta
- 008
- 210728s2021 ts f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2174/0929867327666200425213215 $2 doi
- 035 __
- $a (PubMed)32334495
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ts
- 100 1_
- $a Figueroa-Villar, José Daniel $u Medicinal Chemistry Group, Department of Chemical Engineering, Military Institute of Engineering, 22270- 090, Rio de Janeiro, Brazil
- 245 10
- $a Review about Structure and Evaluation of Reactivators of Acetylcholinesterase Inhibited with Neurotoxic Organophosphorus Compounds / $c JD. Figueroa-Villar, EC. Petronilho, K. Kuca, TCC. Franca
- 520 9_
- $a BACKGROUND: Neurotoxic chemical warfare agents can be classified as some of the most dangerous chemicals for humanity. The most effective of those agents are the Organophosphates (OPs) capable of restricting the enzyme Acetylcholinesterase (AChE), which in turn, controls the nerve impulse transmission. When AChE is inhibited by OPs, its reactivation can be usually performed through cationic oximes. However, until today, it has not been developed one universal defense agent, with complete effective reactivation activity for AChE inhibited by any of the many types of existing neurotoxic OPs. For this reason, before treating people intoxicated by an OP, it is necessary to determine the neurotoxic compound that was used for contamination, in order to select the most effective oxime. Unfortunately, this task usually requires a relatively long time, raising the possibility of death. Cationic oximes also display a limited capacity of permeating the Blood-Brain Barrier (BBB). This fact compromises their capacity to reactivating AChE inside the nervous system. METHODS: We performed a comprehensive search on the data about OPs available on the scientific literature today in order to cover all the main drawbacks still faced in the research for the development of effective antidotes against those compounds. RESULTS: Therefore, this review about neurotoxic OPs and the reactivation of AChE, provides insights for the new agents' development. The most expected defense agent is a molecule without toxicity and effective to reactivate AChE inhibited by all neurotoxic OPs. CONCLUSION: To develop these new agents, the application of diverse scientific areas of research, especially theoretical procedures as computational science (computer simulation, docking and dynamics), organic synthesis, spectroscopic methodologies, biology, biochemical and biophysical information, medicinal chemistry, pharmacology and toxicology, is necessary.
- 650 12
- $a acetylcholinesterasa $7 D000110
- 650 _2
- $a cholinesterasové inhibitory $x toxicita $7 D002800
- 650 12
- $a reaktivátory cholinesterasy $x farmakologie $7 D002801
- 650 _2
- $a počítačová simulace $7 D003198
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a organofosforové sloučeniny $x toxicita $7 D009943
- 650 _2
- $a oximy $x farmakologie $7 D010091
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Petronilho, Elaine C $u Medicinal Chemistry Group, Department of Chemical Engineering, Military Institute of Engineering, 22270- 090, Rio de Janeiro, Brazil
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 50003, Czech Republic
- 700 1_
- $a Franca, Tanos C C $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 50003, Czech Republic
- 773 0_
- $w MED00001274 $t Current medicinal chemistry $x 1875-533X $g Roč. 28, č. 7 (2021), s. 1422-1442
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32334495 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101105 $b ABA008
- 999 __
- $a ok $b bmc $g 1690354 $s 1139954
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 28 $c 7 $d 1422-1442 $e - $i 1875-533X $m Current medicinal chemistry $n Curr Med Chem $x MED00001274
- LZP __
- $a Pubmed-20210728